Vice President, Venture Investments
Noam Krantz is a Vice President of Venture Investments for Johnson & Johnson Innovation – JJDC, Inc. (JJDC), focused on Med Device companies. He is based at the Innovation Center in South San Francisco, CA.
Noam came to JJDC after working for many years in business development and Mergers and Acquisitions, completing over $70 billion in high value growth-oriented transactions, in fields ranging from medical devices and pharmaceuticals to semiconductors and software. In his most recent role as VP, Business Development, he added many platforms and technologies to Ethicon's portfolio, including those in digital surgery (3Di, Auris investment and collaboration), GERD (Torax), Interventional Oncology (NeuWave, Auris collaboration), Wound Closure (barbed sutures) and Energy (Megadyne), to name a few. Noam began his career in Bear Stearns & Co.’s New York investment banking division in 2001, where he worked on advising healthcare and technology companies on M&A and corporate finance transactions. In 2004, he joined Inamed Corporation, as a Senior Manager of Strategy and Corporate Development, and then moved to Mentor Corporation, where he was Vice President of the company’s Corporate Development group, running the Company’s investor relations effort.
Noam has a BS in Biological Sciences from University of California Santa Barbara and an MBA from Columbia Business School.